Literature DB >> 18278455

Protein expression of BLM gene and its apoptosis sensitivity in hematopoietic tumor cell strains.

Xiaobei Wang1, Lihua Hu.   

Abstract

Patients with Bloom syndrome (BS) show an immunodeficiency, an enhanced sister chromatid exchanges (SCEs), a strong genetic instability and an increased predisposition to all. In order to investigate the differential expression of BLM protein in hematopoietic tumor cell strains and study the effects of BLM gene on ultraviolet (UV)-or hydroxyurea (HU)-induced apoptosis, Western blot was used to detect the expression of BLM protein in normal human bone marrow mononuclear cells and 4 kinds of hematopoietic tumor cell strains. The 4 kinds of hematopoietic tumor cells were exposed to UV light with a germicidal UV lamp or treated with 2 mmol/L hydroxyurea and the apoptotic rate was detected by using AnnexinV-FITC. The results showed that these tumor cells expressed BLM protein higher than the normal human bone marrow mononuclear cells (P<0.01). In the 4 hematopoietic tumor cells, BLM protein was all specially cleaved in response to UV-or HU-induced apoptosis. The increase of BLM protein expression may play an important role in the development of these tumors, and BLM proteolysis is likely to be a general feature of the apoptotic response.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18278455     DOI: 10.1007/s11596-008-0111-z

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  8 in total

1.  Cleavage of the Bloom's syndrome gene product during apoptosis by caspase-3 results in an impaired interaction with topoisomerase IIIalpha.

Authors:  R Freire; F d'Adda Di Fagagna; L Wu; G Pedrazzi; I Stagljar; I D Hickson; S P Jackson
Journal:  Nucleic Acids Res       Date:  2001-08-01       Impact factor: 16.971

2.  Bloom helicase is involved in DNA surveillance in early S phase in vertebrate cells.

Authors:  O Imamura; K Fujita; A Shimamoto; H Tanabe; S Takeda; Y Furuichi; T Matsumoto
Journal:  Oncogene       Date:  2001-03-08       Impact factor: 9.867

3.  Role for BLM in replication-fork restart and suppression of origin firing after replicative stress.

Authors:  Sally L Davies; Phillip S North; Ian D Hickson
Journal:  Nat Struct Mol Biol       Date:  2007-06-24       Impact factor: 15.369

4.  Evidence for BLM and Topoisomerase IIIalpha interaction in genomic stability.

Authors:  P Hu; S F Beresten; A J van Brabant; T Z Ye; P P Pandolfi; F B Johnson; L Guarente; N A Ellis
Journal:  Hum Mol Genet       Date:  2001-06-01       Impact factor: 6.150

Review 5.  Bloom syndrome, genomic instability and cancer: the SOS-like hypothesis.

Authors:  Mounira Amor-Guéret
Journal:  Cancer Lett       Date:  2005-06-13       Impact factor: 8.679

6.  Cleavage of BLM and sensitivity of Bloom's syndrome cells to hydroxurea and UV-C radiation.

Authors:  Mouna Ababou; Virginie Dumaire; Yann Lécluse; Mounira Amor-Guéret
Journal:  Cell Cycle       Date:  2002 Jul-Aug       Impact factor: 4.534

Review 7.  Maintenance of genome stability in Saccharomyces cerevisiae.

Authors:  Richard D Kolodner; Christopher D Putnam; Kyungjae Myung
Journal:  Science       Date:  2002-07-26       Impact factor: 47.728

Review 8.  Function of recQ family helicase in genome stability.

Authors:  Masayuki Seki; Shusuke Tada; Takemi Enomoto
Journal:  Subcell Biochem       Date:  2006
  8 in total
  2 in total

1.  Gene expression profile suggesting immunological dysregulation in two Brazilian Bloom's syndrome cases.

Authors:  Marilia M Montenegro; Caio R Quaio; Patricia Palmeira; Yanca Gasparini; Andreia Rangel-Santos; Julian Damasceno; Estela M Novak; Thamires M Gimenez; Guilherme L Yamamoto; Rachel S Ronjo; Gil M Novo-Filho; Samar N Chehimi; Evelin A Zanardo; Alexandre T Dias; Amom M Nascimento; Thais V M M Costa; Alberto J da S Duarte; Luiz L Coutinho; Chong A Kim; Leslie D Kulikowski
Journal:  Mol Genet Genomic Med       Date:  2020-02-19       Impact factor: 2.183

2.  Screening antiproliferative drug for breast cancer from bisbenzylisoquinoline alkaloid tetrandrine and fangchinoline derivatives by targeting BLM helicase.

Authors:  Wangming Zhang; Shuang Yang; Jinhe Liu; Linchun Bao; He Lu; Hong Li; Weidong Pan; Yanchao Jiao; Zhixu He; Jielin Liu
Journal:  BMC Cancer       Date:  2019-10-28       Impact factor: 4.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.